SPNE Pengajuan SEC - SeaSpine Holdings Corp- Laporan Tahunan, Pernyataan Kuasa, Prospektus

Mga Batayang Estadistika

LEI	5493006QNC6E00LJ7M10
CIK	1637761

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to SeaSpine Holdings Corp

SEC Filings (Chronological Order)

Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.

January 17, 2023	15-12G	_____________________________________________________________________________________________________________________________________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20 15-12G 1 spne-form15.htm 15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports Under Sections 13 and 15(d) of the Securities Exchange Act of 1934. Commission File Number: 001-36905 SeaSpine Holdings Corporation (Ex
January 6, 2023	S-8 POS	As filed with the Securities and Exchange Commission on January 5, 2023 As filed with the Securities and Exchange Commission on January 5, 2023 Registration No.
January 6, 2023	S-8 POS	As filed with the Securities and Exchange Commission on January 5, 2023 S-8 POS 1 d431696ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 5, 2023 Registration No. 333-257068 Registration No. 333-240377 Registration No. 333-228217 Registration No. 333-226046 Registration No. 333-225291 Registration No. 333-223435 Registration No. 333-216448 Registration No. 333-211887 Registration No. 333-205334 SECURITIES AND EXCHANGE COMMISSION WASHI
January 6, 2023	S-8 POS	As filed with the Securities and Exchange Commission on January 5, 2023 As filed with the Securities and Exchange Commission on January 5, 2023 Registration No.
January 6, 2023	S-8 POS	As filed with the Securities and Exchange Commission on January 5, 2023 As filed with the Securities and Exchange Commission on January 5, 2023 Registration No.
January 6, 2023	S-8 POS	As filed with the Securities and Exchange Commission on January 5, 2023 S-8 POS 1 d431696ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 5, 2023 Registration No. 333-257068 Registration No. 333-240377 Registration No. 333-228217 Registration No. 333-226046 Registration No. 333-225291 Registration No. 333-223435 Registration No. 333-216448 Registration No. 333-211887 Registration No. 333-205334 SECURITIES AND EXCHANGE COMMISSION WASHI
January 6, 2023	S-8 POS	As filed with the Securities and Exchange Commission on January 5, 2023 As filed with the Securities and Exchange Commission on January 5, 2023 Registration No.
January 6, 2023	POS AM	As filed with the Securities and Exchange Commission on January 5, 2023 POS AM 1 d399002dposam.htm POS AM As filed with the Securities and Exchange Commission on January 5, 2023 Registration No. 333-258527 Registration No. 333-248136 Registration No. 333-216450 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-258527 FORM S-3 REGISTRATION STATEMENT NO. 333-248136 FORM S-3 R
January 6, 2023	S-8 POS	As filed with the Securities and Exchange Commission on January 5, 2023 As filed with the Securities and Exchange Commission on January 5, 2023 Registration No.
January 6, 2023	POS AM	As filed with the Securities and Exchange Commission on January 5, 2023 POS AM 1 d399002dposam.htm POS AM As filed with the Securities and Exchange Commission on January 5, 2023 Registration No. 333-258527 Registration No. 333-248136 Registration No. 333-216450 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-258527 FORM S-3 REGISTRATION STATEMENT NO. 333-248136 FORM S-3 R
January 6, 2023	POS AM	As filed with the Securities and Exchange Commission on January 5, 2023 POS AM 1 d399002dposam.htm POS AM As filed with the Securities and Exchange Commission on January 5, 2023 Registration No. 333-258527 Registration No. 333-248136 Registration No. 333-216450 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT NO. 333-258527 FORM S-3 REGISTRATION STATEMENT NO. 333-248136 FORM S-3 R
January 6, 2023	S-8 POS	As filed with the Securities and Exchange Commission on January 5, 2023 As filed with the Securities and Exchange Commission on January 5, 2023 Registration No.
January 6, 2023	S-8 POS	As filed with the Securities and Exchange Commission on January 5, 2023 S-8 POS 1 d431696ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 5, 2023 Registration No. 333-257068 Registration No. 333-240377 Registration No. 333-228217 Registration No. 333-226046 Registration No. 333-225291 Registration No. 333-223435 Registration No. 333-216448 Registration No. 333-211887 Registration No. 333-205334 SECURITIES AND EXCHANGE COMMISSION WASHI
January 5, 2023	EX-99.1	Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company Orthofix and SeaSpine Stockholders Approve Merger Exhibit 99.1 Orthofix and SeaSpine Announce Completion of Merger of Equals to Create a Leading Global Spine and Orthopedics Company Orthofix and SeaSpine Stockholders Approve Merger Lewisville, Texas ? January 4, 2023 ? Orthofix Medical Inc. (NASDAQ: OFIX) and SeaSpine Holdings Corporation today announced the successful completion of their previously announced merger of equals following the approv
January 5, 2023	EX-3.1	AMENDED AND RESTATED CERTIFICATE OF INCORPORATION SEASPINE HOLDINGS CORPORATION Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEASPINE HOLDINGS CORPORATION 1. The name of the Corporation is: SeaSpine Holdings Corporation (the ?Corporation?). 2. The address of the Corporation?s registered office in the State of Delaware is 251 Little Falls Drive, in the City of Wilmington, County of New Castle, Delaware, 19808. The name of its registered agent at such addres
January 5, 2023	EX-3.2	BYLAWS SeaSpine Holdings Corporation Exhibit 3.2 BYLAWS OF SeaSpine Holdings Corporation TABLE OF CONTENTS Page ARTICLE I OFFICES 1 Section 1.1. Registered Office 1 Section 1.2. Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 Section 2.1. Place of Meetings 1 Section 2.2. Annual Meetings 1 Section 2.3. Special Meetings 1 Section 2.4. Notice of Meeting 1 Section 2.5. Quorum 2 Section 2.6. Adjournments 2 Section 2.7. Voting 2 Sect
January 5, 2023	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2023 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Comm
January 4, 2023	8-K	Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 4, 2023 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Comm
December 27, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2022 SeaSpine Holdin 425 1 d428516d425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdic
December 27, 2022	8-K	Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Co
December 27, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2022 Orthofix Medica 425 1 d398453d425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2022 Orthofix Medical Inc. (Exact name of registrant as specified in its charter) Delaware 0-19961 98-1340767 (State or other jurisdiction of in
December 5, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2022 Orthofix Medical I UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 5, 2022 Orthofix Medical Inc.
November 30, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2022 Orthofix Medical 425 1 d359283d425.htm 425 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2022 Orthofix Medical Inc. (Exact name of Registrant as specified in its charter) Delaware 0-19961 98-1340767 (State or other jurisdiction of inco
November 23, 2022	DEFM14A	SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 DEFM14A 1 d34610ddefm14a.htm DEFM14A Table of Contents SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy Statement
November 21, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2022 Orthofix Medical UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 17, 2022 Orthofix Medical Inc.
November 21, 2022	425	Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
November 18, 2022	425	The following document was issued to employees of Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) on November 17, 2022. 425 1 d345453d425.htm 425 Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following document was issued to employees of Orthofix Medical Inc. (“Orthofix”) and SeaSpine
November 18, 2022	425	The following document was issued to employees of Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) on November 17, 2022. Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
November 18, 2022	425	Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing 425 1 d345453d425.htm 425 Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing
November 3, 2022	EX-10.1	Wells Fargo Amendment Number Four to Amended and Restated Credit Agreement and Waiver Exhibit 10.1 Execution Version AMENDMENT NUMBER FOUR TO AMENDED AND RESTATED CREDIT AGREEMENT AND WAIVER THIS AMENDMENT NUMBER FOUR TO AMENDED AND RESTATED CREDIT AGREEMENT AND WAIVER (this ?Amendment?), dated as of July 15, 2022, is entered into by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association (?Wells Fargo?), as administrative agent for each member of the Lende
November 3, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
November 2, 2022	425	©2022, AlphaSense, Inc. All Rights Reserved. AlphaSense is a service mark of AlphaSense, Inc. All other trademarks mentioned belong to their respective owners. Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
November 1, 2022	425	Stronger Together: Building a Leading Global Spine & Orthopedics Company November 1, 2022 Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Excha Stronger Together: Building a Leading Global Spine & Orthopedics Company November 1, 2022 Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
November 1, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 1, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
November 1, 2022	EX-99.1	SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Quarter 2022 Exhibit 99.1 SeaSpine Announces 45% Revenue Growth and Record Revenue for Third Quarter 2022 CARLSBAD, CA (November 1, 2022) ? SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the third quarter of 2022. Summary Third Quarter 2022 Financial Results and Recent H
November 1, 2022	425	The following presentation was issued by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) on November 1, 2022. Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following presentation was issued by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”)
October 12, 2022	425	1 Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
October 12, 2022	425	The following is a transcript of a joint call hosted by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) on October 11, 2022. Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following is a transcript of a joint call hosted by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporatio
October 11, 2022	425	Filed by SeaSpine Holdings Corporation Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
October 11, 2022	EX-2.1	Agreement and Plan of Merger, dated as of October 10, 2022, by and among Orthofix Medical Inc., Orca Merger Sub Inc. and SeaSpine Holdings Corporation. EX-2.1 Exhibit 2.1 EXECUTION VERSION AGREEMENT AND PLAN OF MERGER by and among ORTHOFIX MEDICAL INC., ORCA MERGER SUB INC., and SEASPINE HOLDINGS CORPORATION Dated October 10, 2022 TABLE OF CONTENTS ARTICLE 1 DEFINITIONS 2 1.01 Definitions 2 1.02 Other Definitional Provisions 15 ARTICLE 2 THE MERGER 16 2.01 Shares of Merger Sub 16 2.02 The Merger 16 2.03 Closing 16 2.04 Effective Time 16 2.05 Effe
October 11, 2022	425	In connection with the pending transaction between Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”), Orthofix posted the following on October 11, 2022. 425 1 d412130d425.htm 425 Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) In connection with the pending transaction between Orthofix Medical Inc. (“Orthofix”) and SeaSpin
October 11, 2022	425	Filed by SeaSpine Holdings Corporation 425 1 d394849d425.htm 425 Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.: 001-36905 Date: October 11, 2022 Creating a New Leader in Spine and Orthopedics October 11, 2022 Sea
October 11, 2022	EX-99.1	SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Quarter 2022 and Raises Full Year 2022 Revenue Guidance EX-99.1 Exhibit 99.1 SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Quarter 2022 and Raises Full Year 2022 Revenue Guidance CARLSBAD, CA (October 11, 2022) – SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the third quarter of
October 11, 2022	425	The following presentation was issued by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) on October 11, 2022. 425 1 d412130d425.htm 425 Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following presentation was issued by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings
October 11, 2022	425	The following document was issued by Orthofix Medical Inc. (“Orthofix”) on October 11, 2022. Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following document was issued by Orthofix Medical Inc. (“Orthofix”) on October 11, 2022. Orthofix – SeaSpine Transactio
October 11, 2022	425	Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) Orthofix Announces Preliminary Third Quarter and Year-To-Date 2022 Net Sales Results • Third quarter net sales of $114 mill
October 11, 2022	EX-99.1	Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company EX-99.1 Exhibit 99.1 Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company • Highly complementary spine and orthopedics portfolios • One of the industry’s broadest biologics and regenerative technology offerings • Differentiated and synergistic enabling technologies • Meaningful cross-selling revenue synergies and cost savings • Financial stren
October 11, 2022	425	The following document was issued by Orthofix Medical Inc. (“Orthofix”) on October 11, 2022. Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following document was issued by Orthofix Medical Inc. (“Orthofix”) on October 11, 2022. Orthofix – SeaSpine Transactio
October 11, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2022 SeaSpine Holding UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Com
October 11, 2022	425	The following infographic was issued by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) on October 11, 2022. Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following infographic was issued by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) o
October 11, 2022	425	SeaSpine Announces 44% to 45% Preliminary Revenue Growth for Third Quarter 2022 and Raises Full Year 2022 Revenue Guidance 425 Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
October 11, 2022	425	Filed by SeaSpine Holdings Corporation Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
October 11, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 11, 2022 (October 10, 202 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 11, 2022 (October 10, 2022) ORTHOFIX MEDICAL INC. (Exact name of registrant as specified in its charter) Delaware 0-19961 98-1340767 (State or other jurisdiction of incorporat
October 11, 2022	425	The following document was issued by Orthofix Medical Inc. (“Orthofix”) on October 11, 2022. 425 1 d412130d425.htm 425 Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following document was issued by Orthofix Medical Inc. (“Orthofix”) on October 11, 2022. Orth
October 11, 2022	425	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2022 SeaSpine Holding UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 10, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Com
October 11, 2022	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2022 SeaSpine Holding UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Com
October 11, 2022	425	Filed by SeaSpine Holdings Corporation 425 Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
October 11, 2022	425	The following presentation was issued by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”) on October 11, 2022. Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following presentation was issued by Orthofix Medical Inc. (“Orthofix”) and SeaSpine Holdings Corporation (“SeaSpine”)
October 11, 2022	425	The following document was issued by Orthofix Medical Inc. (“Orthofix”) on October 11, 2022. 425 Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following document was issued by Orthofix Medical Inc. (“Orthofix”) on October 11, 2022. Orthofix – SeaSpine Transa
October 11, 2022	425	The following documents were issued to employees of Orthofix Medical Inc. (“Orthofix”) on October 11, 2022. Filed by Orthofix Medical Inc. (Commission File No. 0-19961) pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: SeaSpine Holdings Corporation (Commission File No. 001-36905) The following documents were issued to employees of Orthofix Medical Inc. (?Orthofix?) on October 11, 2022. Exciting News:
October 11, 2022	425	Stronger Together: Building a Leading Global Spine & Orthopedics Company October 11, 2022 Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Excha 425 1 d391661d425.htm 425 Stronger Together: Building a Leading Global Spine & Orthopedics Company October 11, 2022 Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.: 001-36905
October 11, 2022	425	Filed by SeaSpine Holdings Corporation Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.
October 11, 2022	425	Filed by SeaSpine Holdings Corporation 425 1 d363925d425.htm 425 Filed by SeaSpine Holdings Corporation pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Filer: SeaSpine Holdings Corporation Subject Company: SeaSpine Holdings Corporation SEC File No.: 001-36905 Date: October 11, 2022 Creating a New Leader in Spine and Orthopedics October 11, 2022 Sea
August 4, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
August 4, 2022	EX-3.1	Amended and Restated Certificate of Incorporation, as amended to date Exhibit 3.1 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEASPINE HOLDINGS CORPORATION SeaSpine Holdings Corporation (the "Corporation"), a corporation organized and existing under the General Corporation Law of the State of Delaware (the "DGCL"), hereby certifies as follows: 1.This Certificate of Amendment (this "Certificate of Amendment") amends the provisions
August 4, 2022	EX-10.1	Standard Industrial/Commercial Single-Tenant Lease–NET between Monarch RRC Properties, LP and Isotis Orthobiologics, Inc., dated June 1, 2022 (filed as an exhibit to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2022 by SeaSpine Holdings Corporation and incorporated herein by reference). Exhibit 10.1 STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE - NET 1.Basic Provisions (?Basic Provisions?). 1.1 Parties. This Lease (?Lease?), dated for reference purposes only June 1, 2022, is made by and between Monarch RRC Properties, LP, a California limited partnership (?Lessor?) and Isotis Orthobiologics, Inc., a Washington corporation (?Lessee?), collectively the ?Parties,? or individual
August 2, 2022	EX-99.1	SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Revenue Guidance Exhibit 99.1 SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Revenue Guidance CARLSBAD, CA (August 2, 2022) – SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today second quarter financial results for the three-months en
August 2, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 2, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
July 18, 2022	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 15, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
June 10, 2022	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 7, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
June 3, 2022	EX-3.1	Certificate of Amendment to Amended and Restated Certificate of Incorporation dated June 1, 2022 Exhibit 3.1 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEASPINE HOLDINGS CORPORATION SeaSpine Holdings Corporation (the "Corporation"), a corporation organized and existing under the General Corporation Law of the State of Delaware (the "DGCL"), hereby certifies as follows: 1.This Certificate of Amendment (this "Certificate of Amendment") amends the provisions
June 3, 2022	8-K	Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 1, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
May 31, 2022	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdict UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 5770 Armada Drive, Carlsbad, California 92008 (Address of principal e
May 9, 2022	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
May 3, 2022	EX-99.1	SeaSpine Reports 21 Percent Revenue Growth for First Quarter 2022 and Increases Full Year 2022 Revenue Guidance Exhibit 99.1 SeaSpine Reports 21 Percent Revenue Growth for First Quarter 2022 and Increases Full Year 2022 Revenue Guidance CARLSBAD, CA (May 3, 2022) ? SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months ended March 31, 2022. Summary First Quar
May 3, 2022	8-K	Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 2, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
May 3, 2022	EX-99.2	SeaSpine® Announces New Senior Leadership Team Appointments Exhibit 99.2 SeaSpine? Announces New Senior Leadership Team Appointments CARLSBAD, CA May 3, 2022 (GLOBAL NEWSWIRE) ? SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that John Bostjancic, previously the Company?s Senior Vice President, Chief Financial Officer, has assumed expanded
April 22, 2022	DEF 14A	SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 DEF 14A 1 spnedefproxystatement2022.htm DEF 14A SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ýDefinitive Proxy Statement oDefinitiv
April 22, 2022	DEFA14A	SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Proxy Statement ?Definitive Additional Materials oSoliciting Material under ?240.
April 8, 2022	PRE 14A	SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 PRE 14A 1 prelimproxystatementv-84x0.htm PRE 14A SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: ýPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Proxy Statement oDefinitive A
March 15, 2022	EX-10.17(G)	OMNIBUS JOINDER AND THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND OTHER LOAN DOCUMENTS OMNIBUS JOINDER AND THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND OTHER LOAN DOCUMENTS THIS OMNIBUS JOINDER AND THIRD AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT AND OTHER LOAN DOCUMENTS (this ?Amendment?) is made as of October 26, 2021, by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as administrative agent for each member of the Lender G
March 15, 2022	EX-21.1	Subsidiaries of Registrant EXHIBIT 21.1 Subsidiaries of SeaSpine Holdings Corporation Name of Subsidiary State or Country of Incorporation or Organization IsoTis International SARL Switzerland IsoTis OrthoBiologics, Inc. Washington IosTis, Inc. Delaware SeaSpine, Inc. Delaware SeaSpine Sales LLC Delaware SeaSpine Orthopedics Corporation Delaware Theken Spine, LLC Ohio SeaSpine Orthopedics IntermediateCo, Inc. Delaware Proje
March 15, 2022	10-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
March 11, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 11, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
March 11, 2022	EX-99.1	SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Revenue Guidance Exhibit 99.1 SeaSpine Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides 2022 Revenue Guidance CARLSBAD, CA (March 11, 2022) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2021. Summ
February 14, 2022	EX-99.2	JOINT FILING AGREEMENT Exhibit 99.2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including amendments thereto) with respect to the common stock, par value $0.01 per share of SeaSpine Holdings Corporation, and further agree that this Joint Filing Agr
February 14, 2022	SC 13G/A	SPNE / SeaSpine Holdings Corp / Tru St Partnership, L.P. - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 7)* SEASPINE HOLDINGS CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 81255T 108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa
February 14, 2022	SC 13G	SPNE / SeaSpine Holdings Corp / Avidity Partners Management LP Passive Investment SC 13G 1 d917870113g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* SeaSpine Holdings Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 81255T108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the approp
February 14, 2022	EX-99.1	Group Members Tru St Partnership LP Provco Leasing Corporation Exhibit 99.1 Group Members Tru St Partnership LP Provco Leasing Corporation
February 14, 2022	SC 13G/A	SPNE / SeaSpine Holdings Corp / First Light Asset Management, LLC - AMENDMENT TO FORM SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934* SeaSpine Holdings Corporation (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81255T108 (CUSIP Number) December 31, 2021 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi
January 10, 2022	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 10, 2022 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
January 10, 2022	EX-99.1	SeaSpine Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results, Including Record Fourth Quarter 2021 Revenue Exhibit 99.1 SeaSpine Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results, Including Record Fourth Quarter 2021 Revenue CARLSBAD, CA. (January 10, 2022) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and
December 14, 2021	EX-99.1	SeaSpine Appoints Seasoned Healthcare Executive to its Board of Directors Exhibit 99.1 SeaSpine Appoints Seasoned Healthcare Executive to its Board of Directors CARLSBAD, CA / December 14, 2021 ? SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has appointed Angela Steinway to its Board of Directors, effective December 14, 2021. Ms. Steinway will
December 14, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 14, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
November 3, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
October 28, 2021	EX-99.1	SeaSpine Reports Third Quarter 2021 Financial Results Provides Financial Outlook for Fourth Quarter 2021 Exhibit 99.1 SeaSpine Reports Third Quarter 2021 Financial Results Provides Financial Outlook for Fourth Quarter 2021 CARLSBAD, CA (October 28, 2021) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended September 30, 2021. Summary of Third
October 28, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 28, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
September 24, 2021	8-K	Regulation FD Disclosure, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): September 24, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
August 9, 2021	CORRESP	August 9, 2021 August 9, 2021 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Mr.
August 5, 2021	EX-10.4	Beau Standish Letter Agreement, dated May 22, 2021 Exhibit 10.4 Dear 7D Team Member, It?s with great pride that we welcome you to the SeaSpine family! Through our strategic partnership, we were able to appreciate the unique alignment of the respective vision and culture of our two organizations. This led to deepening our collaboration to come together as one team committed to advancing and improving surgery with a steadfast focus on safety and pat
August 5, 2021	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
August 5, 2021	EX-10.2	Amendment Agreement to the Arrangement Agreement Exhibit 10.2 AMENDMENT AGREEMENT Dated May 19, 2021 Reference is made to the Arrangement Agreement among SeaSpine Holdings Corporation (?Parent?), Project Maple Leaf Acquisition ULC (?Purchaser?), 7D Surgical Inc. (the ?Company?) and Michael Cadotte and Joel Rose in their capacity as shareholder representatives (the ?Shareholder Representatives?) dated March 22, 2021 (the ?Arrangement Agreement?).
August 5, 2021	EX-10.3	Consent and Agreement Under Amended and Restated Credit Agreement, dated May 20, 2021, among Wells Fargo Bank, National Association, and SeaSpine Holdings Corporation, SeaSpine Orthopedics Corporation, SeaSpine, Inc., Isotis Inc., SeaSpine Sales LLC, Theken Spine, LLC, and Isotis Orthobiologics, Inc. Exhibit 10.3 CONSENT AND AGREEMENT UNDER AMENDED AND RESTATED CREDIT AGREEMENT CONSENT AND AGREEMENT UNDER AMENDED AND RESTATED CREDIT AGREEMENT (this ?Agreement?) is made as of May 20, 2021, by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in such capacity, together with
August 5, 2021	S-3	As filed with the Securities and Exchange Commission on August 5, 2021 As filed with the Securities and Exchange Commission on August 5, 2021 Registration No.
August 2, 2021	EX-99.1	SeaSpine Reports Second Quarter 2021 Financial Results Announces Record Quarterly Revenue Updates 2021 Financial Outlook; Raises Bottom End of Guidance Range Exhibit 99.1 SeaSpine Reports Second Quarter 2021 Financial Results Announces Record Quarterly Revenue Updates 2021 Financial Outlook; Raises Bottom End of Guidance Range CARLSBAD, CA (August 2, 2021) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the thre
August 2, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 2, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
July 28, 2021	EX-99.1	Notes to consolidated financial statements EXHIBIT 99.1 Disclaimer Ernst & Young LLP (EY) prepared the attached Report only for Client pursuant to an agreement solely between EY and Client. EY did not perform its services on behalf of or to serve the needs of any other person or entity. Accordingly, EY expressly disclaims any duties or obligations to any other person or entity based on its use of the attached Report. Any other person or en
July 28, 2021	8-K/A	Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A (Amendment No.
July 28, 2021	EX-99.2	SEASPINE HOLDINGS CORPORATION UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS EXHIBIT 99.2 SEASPINE HOLDINGS CORPORATION UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS On May 20, 2021, SeaSpine Holdings Corporation (the "Company"), announced the closing of the previously announced acquisition (the "Transaction") of 7D Surgical Inc. (the "7D"), a Toronto-based company that develops advanced optical technologies and machine vision-based registration algorithms to improve s
June 14, 2021	S-8	As filed with the Securities and Exchange Commission on June 14, 2021 As filed with the Securities and Exchange Commission on June 14, 2021 Registration No.
June 4, 2021	EX-3.2	Amended and Restated Bylaws, as amended to date Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF SEASPINE HOLDINGS CORPORATION (As amended as of June 2, 2021) ARTICLE I Meetings of Stockholders Section 1.1. Annual Meetings. The annual meeting of the stockholders of SeaSpine Holdings Corporation (the ?Corporation?) for the election of directors (each, a ?Director?) and for the transaction of such other business as properly may come before such meeting
June 4, 2021	EX-3.1	Certificate of Amendment to Amended and Restated Certificate of Incorporation dated June 2, 2021 Exhibit 3.1 CERTIFICATE OF AMENDMENT OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SEASPINE HOLDINGS CORPORATION SeaSpine Holdings Corporation (the "Corporation"), a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows: 1.This Certificate of Amendment (the "Certificate of Amendment") amends the provisions of the Corpor
June 4, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 2, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
May 21, 2021	8-K	Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 20, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commiss
May 14, 2021	SD	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdict UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 5770 Armada Drive, Carlsbad, California 92008 (Address of principal e
May 7, 2021	DEFA14A	- DEFA14A SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Proxy Statement ?Definitive Additional Materials oSoliciting Material under ?240.
May 3, 2021	EX-99.1	SeaSpine Reports First Quarter 2021 Financial Results Reaffirms 2021 Financial Outlook EX-99.1 2 spne8-kq12021exhibit991.htm EX-99.1 Exhibit 99.1 SeaSpine Reports First Quarter 2021 Financial Results Reaffirms 2021 Financial Outlook CARLSBAD, CA (May 3, 2021) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended March 31, 202
May 3, 2021	EX-10.1	Supply Agreement between SeaSpine Orthopedics Corporation and PcoMed, LLC, dated March 1, 2021 (filed as an exhibit to the Quarterly Report on Form 10-Q for the quarter ended March 31, 2021 by SeaSpine Holdings Corporation and incorporated herein by reference). Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH ?[***]?. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF DISCLOSED. SUPPLY AGREEMENT THIS SUPPLY AGREEMENT (this ?Agreement?), effective March 1, 2021 (the ?Effective Date?), is by and between Se
May 3, 2021	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
May 3, 2021	EX-10.2	Amended and Restated Non-Employee Director Compensation Program, effective June 2, 2020 EX-10.2 3 spne20210331excompprogram.htm EX-10.2 Exhibit 10.2 SEASPINE HOLDINGS CORPORATION NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM Amended and Restated Effective June 2, 2021 This SeaSpine Holdings Corporation (the “Company”) Non-Employee Director Compensation Program (this “Program”) for non-employee directors (the “Directors”) of the board of directors of the Company (the “Board”) shall be ef
May 3, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 3, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
April 21, 2021	DEF 14A	Second Amendment to the SeaSpine Holdings Corporation 2015 Employee Stock Purchase Plan (December 9, 2020) SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) xDefinitive Proxy Statement oDefinitive Additional Materials oSoliciting Material under ?240.
April 21, 2021	DEFA14A	- DEFA14A SCHEDULE 14A INFORMATION (Rule 14a-101)PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Proxy Statement ?Definitive Additional Materials oSoliciting Material under ?240.
April 19, 2021	EX-1.1	Underwriting Agreement, dated April 15, 2021, by and among SeaSpine Holdings Corporation, Piper Sandler & Co., Canaccord Genuity LLC, and Stifel, Nicolaus & Company EX-1.1 2 d167794dex11.htm EX-1.1 Exhibit 1.1 Execution Version SeaSpine Holdings Corporation 4,500,000 Shares of Common Stock UNDERWRITING AGREEMENT Dated: April 15, 2021 TABLE OF CONTENTS Page SECTION 1. Representations and Warranties 2 SECTION 2. Sale and Delivery to Underwriters; Closing 17 SECTION 3. Covenants of the Company 19 SECTION 4. Payment of Expenses 23 SECTION 5. Conditions of Underwr
April 19, 2021	EX-99.1	SeaSpine Commences Public Offering of Common Stock EX-99.1 4 d167794dex991.htm EX-99.1 Exhibit 99.1 SeaSpine Commences Public Offering of Common Stock CARLSBAD, CA. (April 15, 2021) – SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has commenced an underwritten public offering of shares of its
April 19, 2021	424B5	The date of this prospectus supplement is April 15, 2021 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-236802 PROSPECTUS SUPPLEMENT (To Prospectus Dated February 4, 2021) SeaSpine Holdings Corporation 4,500,000 Shares Common Stock We are offering 4,500,000 shares of our common stock. Our common stock trades on The Nasdaq Global Select Market under the symbol ?SPNE.? On April 15, 2021, the last sale price of the common stock rep
April 19, 2021	EX-99.2	April 15, 2021 Exhibit 99.2 April 15, 2021 SeaSpine Prices Public Offering of Common Stock CARLSBAD, CA. (April 15, 2021) ? SeaSpine Holdings Corporation (NASDAQ: SPNE) (?SeaSpine? or the ?Company?), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced underwritten public offering of 4,500,000 shares of it
April 19, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commi
April 15, 2021	424B5	SUBJECT TO COMPLETION, DATED April 15, 2021 Table of Contents The information in this preliminary prospectus supplement is not complete and may be changed.
April 9, 2021	PRE 14A	- PRE 14A SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ? Filed by a Party other than the Registrant o Check the appropriate box: ?Preliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Proxy Statement oDefinitive Additional Materials oSoliciting Material under ?240.
April 5, 2021	EX-99.1	SeaSpine Announces Preliminary Results for First Quarter 2021 and Increases 2021 Revenue Guidance Provides Additional Financial Guidance for Pending Acquisition of 7D Surgical Exhibit 99.1 SeaSpine Announces Preliminary Results for First Quarter 2021 and Increases 2021 Revenue Guidance Provides Additional Financial Guidance for Pending Acquisition of 7D Surgical CARLSBAD, CA. (April 5, 2021) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary
April 5, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 5, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
April 1, 2021	EX-99.1	SeaSpine Appoints Google Executive and Healthcare Thought Leader to its Board of Directors EX-99.1 2 spnemaniarappointmentex991.htm EX-99.1 Exhibit 99.1 SeaSpine Appoints Google Executive and Healthcare Thought Leader to its Board of Directors CARLSBAD, CA / April 1, 2021 – SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has appointed Shweta Singh Maniar to its
April 1, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 31, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
March 24, 2021	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commi
March 24, 2021	EX-10.1	Arrangement Agreement, dated March 22, 2021, by and among SeaSpine Holdings Corporation, 7D Surgical Inc. and Project Maple Leaf Acquisition ULC EX-10.1 2 d96361dex101.htm EX-10.1 Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF DISCLOSED. SEASPINE HOLDINGS CORPORATION as Parent - and - PROJECT MAPLE LEAF ACQUISITION ULC as Purcha
March 22, 2021	8-K	Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commi
March 22, 2021	EX-99.1	Forward-looking Statements & Disclaimer This presentation includes statements that may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “estimate,” “expect,” “anticipate,” Exhibit 99.1 SeaSpine + 7D Surgical A Powerful Combination: Accessing the Full Continuum of Care Keith C. Valentine Beau Standish, PEng, PhD President & Chief Executive Officer Chief Executive Officer ?2021 SeaSpine Orthopedics Corporation. All rights reserved. 1Exhibit 99.1 SeaSpine + 7D Surgical A Powerful Combination: Accessing the Full Continuum of Care Keith C. Valentine Beau Standish, PEng,
March 5, 2021	EX-10.18(B)	Amendment 10 to the Supply Agreement between SeaSpine Orthopedics Corporation and PcoMed, LLC Exhibit 10.18(b) AMENDMENT NO. 10 TO SUPPLY AGREEMENT This Amendment No. 10 to Supply Agreement (this “Amendment”) is entered into effective as of December 1, 2020 (the “Effective Date”) by and between SeaSpine Orthopedics Corporation, a Delaware corporation (“SeaSpine”), and PcoMed, LLC, a Colorado limited liability company (“PcoMed”). WHEREAS, SeaSpine and PcoMed are parties to a certain Supply
March 5, 2021	10-K	Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
March 1, 2021	EX-99.1	SeaSpine Announces Fourth Quarter and Full-Year 2020 Results Reports Record Quarterly Revenue, Driven by U.S. Sales Channel Exhibit 99.1 SeaSpine Announces Fourth Quarter and Full-Year 2020 Results Reports Record Quarterly Revenue, Driven by U.S. Sales Channel CARLSBAD, CA (March 1, 2021) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended Decemb
March 1, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 1, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
February 16, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* SEASPINE HOLDINGS CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class o SC 13G/A 1 tm216525d2sc13ga.htm SCHEDULE 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* SEASPINE HOLDINGS CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 81255T 108 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this
February 3, 2021	S-3/A	- S-3/A As filed with the Securities and Exchange Commission on February 3, 2021 Registration No.
February 2, 2021	CORRESP	- February 2, 2021 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Mr.
February 2, 2021	S-3/A	- S-3/A S-3/A 1 s-3a2021february.htm S-3/A As filed with the Securities and Exchange Commission on February 2, 2021 Registration No. 333-236802 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SeaSpine Holdings Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 5770 Armada Dr
January 29, 2021	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 28, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
January 29, 2021	EX-10.1	SeaSpine Holdings Corporation Amended and Restated 2015 Incentive Award Plan Annual Incentive Program EX-10.1 2 a2015plan-annualincentivep.htm EX-10.1 Exhibit 10.1 SEASPINE HOLDINGS CORPORATION AMENDED AND RESTATED 2015 INCENTIVE AWARD PLAN ANNUAL INCENTIVE PROGRAM (beginning January 1, 2019) This Annual Incentive Program (beginning January 1, 2019) (hereinafter referred to as the “Program”) is hereby adopted under Section 9.1(b) the SeaSpine Holdings Corporation (the “Company”) Amended and Restat
January 11, 2021	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 11, 2021 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
January 11, 2021	EX-99.1	SeaSpine Announces Preliminary Results and Record Quarterly Revenue, Driven by U.S. Sales Channel EX-99.1 2 q420exhibit991prelimresults.htm EX-99.1 EXHIBIT 99.1 SeaSpine Announces Preliminary Results and Record Quarterly Revenue, Driven by U.S. Sales Channel CARLSBAD, CA. (January 11, 2021) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the
January 8, 2021	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934* SC 13G/A 1 spne-sc13ga010821.htm AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934* SeaSpine Holdings Corporation (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81255T108 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of th
December 30, 2020	SC 13G/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* SeaSpine Holdings Corp (Name of Issuer) Common Stock (Title of class of securities) (CUSIP number) Decem SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* SeaSpine Holdings Corp (Name of Issuer) Common Stock (Title of class of securities) 81255T108 (CUSIP number) December 30, 2020 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to wh
December 29, 2020	8-K	Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 21, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
December 11, 2020	EX-3.1	Amended and Restated Bylaws, as amended to date EX-3.1 2 bylawamendment2020.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF SEASPINE HOLDINGS CORPORATION (As amended as of February 28, 2019December 9, 2020) ARTICLE I Meetings of Stockholders Section 1.1. Annual Meetings. The annual meeting of the stockholders of SeaSpine Holdings Corporation (the “Corporation”) for the election of directors (each, a “Director”) and for the transaction of
December 11, 2020	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 9, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
November 9, 2020	EX-99.1	SeaSpine Reports Third Quarter 2020 Financial Results Exhibit 99.1 SeaSpine Reports Third Quarter 2020 Financial Results CARLSBAD, CA (November 9, 2020) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended September 30, 2020. Summary of Third Quarter 2020 Financial Results and Recent Accompli
November 9, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 9, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
November 9, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
October 6, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 6, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
October 6, 2020	EX-99.1	SeaSpine Provides Preliminary Results for Third Quarter 2020 and Revenue Guidance for Fourth Quarter 2020 Exhibit 99.1 SeaSpine Provides Preliminary Results for Third Quarter 2020 and Revenue Guidance for Fourth Quarter 2020 CARLSBAD, CA. (October 6, 2020) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the third quarter of 2020 and provided a reven
August 27, 2020	CORRESP	- August 27, 2020 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Ms.
August 27, 2020	S-3/A	- S-3/A S-3/A 1 s-3a2020nlt.htm S-3/A As filed with the Securities and Exchange Commission on August 27, 2020 Registration No. 333-248136 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SeaSpine Holdings Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 5770 Armada Drive Ca
August 27, 2020	CORRESP	- DLA Piper LLP (US) 4365 Executive Drive, Suite 1100 San Diego, California 92121-2133 www.
August 19, 2020	S-3	- S-3 S-3 1 s-32020nlt.htm S-3 As filed with the Securities and Exchange Commission on August 19, 2020 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SeaSpine Holdings Corporation (Exact Name of Registrant as Specified in Its Charter) Delaware 5770 Armada Drive Carlsbad, CA 92008 (760) 727-839
August 4, 2020	S-8	- S-8 As filed with the Securities and Exchange Commission on August 4, 2020 Registration No.
August 4, 2020	EX-10.1	Consent Under and First Amendment to Amended and Restated Credit Agreement EXHIBIT 10.1 CONSENT UNDER AND FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT THIS CONSENT UNDER AND FIRST AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is made as of April 24, 2020, by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in suc
August 4, 2020	EX-99.1	SeaSpine Reports Second Quarter 2020 Financial Results Exhibit 99.1 SeaSpine Reports Second Quarter 2020 Financial Results CARLSBAD, CA (August 4, 2020) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three months ended June 30, 2020. Summary of Second Quarter 2020 Financial Results and Recent Accomplishmen
August 4, 2020	EX-10.5	SeaSpine Holdings Corporation 2020 Employment Inducement Incentive Award Plan EXHIBIT 10.5 SEASPINE HOLDINGS CORPORATION 2020 EMPLOYMENT INDUCEMENT INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE The purpose of the SeaSpine Holdings Corporation 2020 Employment Inducement Incentive Award Plan (the “Plan”) is to promote the success and enhance the value of SeaSpine Holdings Corporation, a Delaware corporation (the “Company”), by linking the individual interests of Eligible Individual
August 4, 2020	EX-10.6	Form of 2020 Employment Inducement Incentive Award Plan Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the SeaSpine Holdings Corporation 2020 Employment Inducement Incentive Award Plan EXHIBIT 10.6 SEASPINE HOLDINGS CORPORATION 2020 EMPLOYMENT INDUCEMENT INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE AND RESTRICTED STOCK UNIT AWARD AGREEMENT SeaSpine Holdings Corporation, a Delaware corporation (the “Company”), pursuant to its 2020 Employment Inducement Incentive Award Plan (as may be amended and/or restated from time to time, the “Plan”), hereby grants to the ind
August 4, 2020	EX-10.8	Form of Stock Option Grant Notice and Stock Option Agreement under the SeaSpine Holdings Corporation 2020 Employment Inducement Incentive Award Plan (for Non-Senior Leadership Team Members) EXHIBIT 10.8 SEASPINE HOLDINGS CORPORATION 2020 EMPLOYMENT INDUCEMENT INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE SeaSpine Holdings Corporation, a Delaware corporation (the “Company”), pursuant to its 2020 Employment Inducement Incentive Award Plan (as may be amended and/or restated from time to time, the “Plan”), hereby grants to the individual listed below (the “Optionee”), an option to purch
August 4, 2020	10-Q	Quarterly Report - 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
August 4, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 4, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
August 4, 2020	EX-10.7	Form of Stock Option Grant Notice and Stock Option Agreement under the SeaSpine Holdings Corporation 2020 Employment Inducement Incentive Award Plan (for Senior Leadership Team Members) EXHIBIT 10.7 SEASPINE HOLDINGS CORPORATION 2020 EMPLOYMENT INDUCEMENT INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE SeaSpine Holdings Corporation, a Delaware corporation (the “Company”), pursuant to its 2020 Employment Inducement Incentive Award Plan (as may be amended and/or restated from time to time, the “Plan”), hereby grants to the individual listed below (the “Optionee”), an option to purch
July 31, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): July 30, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
July 31, 2020	EX-10.1	Second Amendment to Amended and Restated Credit Agreement made as of July 30, 2020 by and among Wells Fargo Bank, N.A., as administrative agent for each member of the lender group and the bank product providers, the lenders party thereto, SeaSpine Holdings Corporation, SeaSpine Orthopedics Corporation, SeaSpine, Inc., ISOTIS, Inc., SeaSpine Sales LLC, Theken Spine, LLC, and IsoTis Orthobiologics, Inc. Exhibit 10.1 SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT THIS SECOND AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is made as of July 30, 2020, by and among WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as administrative agent for each member of the Lender Group and the Bank Product Providers (in such capacity, together with its succe
June 5, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): June 3, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
May 15, 2020	SD	- SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 5770 Armada Drive, Carlsbad, California 92008 (Address of principal e
May 6, 2020	EX-99.1	SeaSpine Reports First Quarter 2020 Financial Results Exhibit 99.1 SeaSpine Reports First Quarter 2020 Financial Results CARLSBAD, CA (May 6, 2020) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced financial results for the three-months ended March 31, 2020. Summary of First Quarter 2020 Financial Results and Recent Accomplishments •
May 6, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 spne8-kq12020earningsrelea.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 6, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other
May 6, 2020	10-Q	Quarterly Report - 10-Q 10-Q 1 spne2020033110-q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION F
April 24, 2020	EX-10.1	Letter agreement dated April 23, 2020 with Keith C. Valentine Exhibit 10.1 April 23, 2020 Reference is made to that certain Employment Agreement, between SeaSpine Holdings Corporation, a Delaware corporation, SeaSpine Orthopedics Corporation, a Delaware corporation, and Keith Valentine (“Executive”) entered into and effective as of April 28, 2015, as amended pursuant to that certain Amendment to Employment Agreement, entered into and effective as of April 30
April 24, 2020	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 23, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
April 24, 2020	EX-10.2	Form of letter agreement dated April 23, 2020 with members of the senior leadership team of SeaSpine Holdings Corporation other than Keith C. Valentine Exhibit 10.2 April 23, 2020 Reference is made to that certain Senior Leadership Retention and Severance Plan (effective January 27, 2016, with Exhibit A updated as of August 22, 2018) (the “Plan”). The undersigned (“Participant”) hereby consents to a reduction in Participant’s base salary equal to 25% of Participant’s base salary on the date set forth above, which reduction will be effective begin
April 20, 2020	DEF 14A	Amendment to the SeaSpine Holdings Corporation Amended and Restated 2015 Incentive Award Plan (effective June 3, 2020) SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ýDefinitive Proxy Statement oDefinitive Additional Materials oSoliciting Material under §240.
April 20, 2020	DEFA14A	SPNE / SeaSpine Holdings Corporation DEFA14A - - DEFA14A DEFA14A 1 a2020spnedefa14a.htm DEFA14A SCHEDULE 14A INFORMATION (Rule 14a-101)PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Proxy Statement ýDefi
April 6, 2020	8-K	Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 6, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
April 6, 2020	EX-99.1	SeaSpine Provides Preliminary Results for First Quarter 2020 and COVID-19 Related Business Update Strong Cash Position of Approximately $105 Million Provides Operational Stability Company Withdraws Guidance for 2020 Exhibit 99.1 SeaSpine Provides Preliminary Results for First Quarter 2020 and COVID-19 Related Business Update Strong Cash Position of Approximately $105 Million Provides Operational Stability Company Withdraws Guidance for 2020 CARLSBAD, CA. (April 6, 2020) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal
February 28, 2020	EX-4.4	Form of Indenture for Subordinated Debt Securities EX-4.4 3 exhibit44-formsubordinated.htm EXHIBIT 4.4 Exhibit 4.4 SEASPINE HOLDINGS CORPORATION, ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securiti
February 28, 2020	S-3	SPNE / SeaSpine Holdings Corporation S-3 - - S-3 As filed with the Securities and Exchange Commission on February 28, 2020 Registration No.
February 28, 2020	10-K	SPNE / SeaSpine Holdings Corporation 10-K - Annual Report - 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
February 28, 2020	EX-10.12I	SeaSpine Holdings Corporation Amended and Restated 2015 Incentive Award Plan - Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement. (used for grants on and after January 1, 2020) EXHIBIT 10.12(i) SEASPINE HOLDINGS CORPORATION 2015 INCENTIVE AWARD PLAN RESTRICTED STOCK AWARD GRANT NOTICE AND RESTRICTED STOCK AWARD AGREEMENT SeaSpine Holdings Corporation, a Delaware corporation (the “Company”), pursuant to its 2015 Incentive Award Plan (as may be amended and/or restated from time to time, the “Plan”), hereby grants to the individual listed below (the “Participant”), an award
February 28, 2020	EX-4.3	Form of Senior Indenture Exhibit 4.3 SEASPINE HOLDINGS CORPORATION, ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.1 Definitions of Terms 1 ARTICLE II ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.1 Designation and Terms of Securities 4 Section 2.2 Form of Securities and Trustee’s Certifica
February 28, 2020	EX-4.4	Description of securities of the registrant EXHIBIT 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 As of February 21, 2020, SeaSpine Holdings Corporation (the "Company," "we," "our" and "us") had one classes of securities registered under Section 12 of the Securities Exchange Act of 1934 (the “Exchange Act”): common stock, $0.01 par value per share (“common stock”). Ge
February 26, 2020	EX-99.1	SeaSpine Announces Fourth Quarter and Full-Year 2019 Results and Reaffirms 2020 Revenue Guidance Exhibit 99.1 SeaSpine Announces Fourth Quarter and Full-Year 2019 Results and Reaffirms 2020 Revenue Guidance CARLSBAD, CA (February 26, 2020) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2019 and reaffir
February 26, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 26, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
February 14, 2020	SC 13G/A	SPNE / SeaSpine Holdings Corporation / First Light Asset Management, LLC - AMENDMENT TO FORM SC 13G Passive Investment SC 13G/A 1 spne-sc13ga021220.htm AMENDMENT TO FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934* SeaSpine Holdings Corporation (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81255T108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check
February 11, 2020	EX-99.1	Group Members Richard E. Caruso, Ph.D. Tru St Partnership LP Provco Leasing Corporation The Uncommon Individual Foundation Exhibit 99.1 Group Members Richard E. Caruso, Ph.D. Tru St Partnership LP Provco Leasing Corporation The Uncommon Individual Foundation
February 11, 2020	EX-99.2	JOINT FILING AGREEMENT Exhibit 99.2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including amendments thereto) with respect to the common stock, par value $0.01 per share of SeaSpine Holdings Corporation, and further agree that this Joint Filing Agr
February 11, 2020	SC 13G/A	SPNE / SeaSpine Holdings Corporation / CARUSO RICHARD E - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* SEASPINE HOLDINGS CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 81255T 108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa
February 5, 2020	SC 13G/A	SPNE / SeaSpine Holdings Corporation / Novo A/S - AMENDMENT NO. 2 TO SCHEDULE 13G Passive Investment Amendment No. 2 to Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* SeaSpine Holdings Corp (Name of Issuer) Common Stock (Title of class of securities) 81255T108 (CUSIP number) December 31, 2019 (Date of event which requires filing of this statement) Check the appropriate box to designate
January 28, 2020	SC 13G	SPNE / SeaSpine Holdings Corporation / FALCON POINT CAPITAL, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Seaspine Holdings Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 81255T108 (CUSIP Number) December 31, 2019 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
January 9, 2020	SC 13G/A	SPNE / SeaSpine Holdings Corporation / First Light Asset Management, LLC - AMENDMENT TO FORM SC 13G Passive Investment SC 13G/A 1 spne-sc13ga010820.htm AMENDMENT TO FORM SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934* SeaSpine Holdings Corporation (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81255T108 (CUSIP Number) January 8, 2020 (Date of Event Which Requires Filing of this Statement) Check t
January 8, 2020	EX-99.2	January 7, 2020 EX-99.2 Exhibit 99.2 January 7, 2020 SeaSpine Prices Public Offering of Common Stock CARLSBAD, CA. (January 7, 2020) – SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the pricing of its previously announced underwritten public offering of 6,800,000 sh
January 8, 2020	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (
January 8, 2020	424B5	The date of this prospectus supplement is January 7, 2020 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-230047 PROSPECTUS SUPPLEMENT (To Prospectus Dated May 22, 2019) SeaSpine Holdings Corporation 6,800,000 Shares Common Stock We are offering 6,800,000 shares of our common stock. Our common stock trades on The Nasdaq Global Market under the symbol “SPNE.” On January 7, 2020, the last sale price of the common stock reporte
January 8, 2020	EX-99.1	January 7, 2020 EX-99.1 Exhibit 99.1 January 7, 2020 SeaSpine Commences Public Offering of Common Stock CARLSBAD, CA. (January 7, 2020) – SeaSpine Holdings Corporation (NASDAQ: SPNE) (“SeaSpine” or the “Company”), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has commenced an underwritten public offering of shares of its common sto
January 8, 2020	EX-1.1	Underwriting Agreement, dated January 7, 2020, by and among SeaSpine Holdings Corporation, Piper Sandler & Co. and Canaccord Genuity LLC EX-1.1 Exhibit 1.1 Execution Version SeaSpine Holdings Corporation 6,800,000 Shares of Common Stock UNDERWRITING AGREEMENT Dated: January 7, 2020 TABLE OF CONTENTS Page SECTION 1. Representations and Warranties 2 SECTION 2. Sale and Delivery to Underwriters; Closing 16 SECTION 3. Covenants of the Company 17 SECTION 4. Payment of Expenses 21 SECTION 5. Conditions of Underwriters’ Obligations 22 SEC
January 7, 2020	424B5	SUBJECT TO COMPLETION, DATED JANUARY 7, 2020 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-230047 The information in this preliminary prospectus supplement is not complete and may be changed. Neither this preliminary prospectus supplement nor the accompanying prospectus is an offer to sell these securities, and we are not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale
January 7, 2020	EX-99.1	SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2019; Reports Record Revenue, Driven by Greater Than 20% U.S. Spinal Implants Growth Provides Revenue Guidance for 2020 EX-99.1 2 d861804dex991.htm EX-99.1 Exhibit 99.1 SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2019; Reports Record Revenue, Driven by Greater Than 20% U.S. Spinal Implants Growth Provides Revenue Guidance for 2020 CARLSBAD, CA. (January 7, 2020)—SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatme
January 7, 2020	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2020 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (
October 29, 2019	10-Q	September 30, 2019 10-Q 1 spne2019093010-q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSI
October 29, 2019	EX-96.1	Press release dated October 29, 2019 Exhibit 99.1 SeaSpine Reports Record Revenue, Driven by 16% U.S. Spinal Implants Growth Increases 2019 total revenue guidance to between $157 million and $158 million Implies 10% to 12% growth over fourth quarter 2018 CARLSBAD, CA (October 29, 2019) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorder
October 29, 2019	8-K	Termination of a Material Definitive Agreement, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 23, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
August 1, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 1, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
August 1, 2019	EX-99.1	SeaSpine Reports Second Quarter 2019 Financial Results Increases 2019 Financial Outlook Exhibit 99.1 SeaSpine Reports Second Quarter 2019 Financial Results Increases 2019 Financial Outlook CARLSBAD, CA (Aug 1, 2019) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended June 30, 2019 and updated its financial outlook for 2019. Summa
August 1, 2019	10-Q	June 30, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
May 31, 2019	EX-10.1	Form of Indemnification Agreement entered into between SeaSpine Holdings Corporation and each of its directors and officers EX-10.1 2 spneexhibit101.htm EXHIBIT 10.1 Exhibit 10.1 INDEMNIFICATION AGREEMENT This Indemnification Agreement (“Agreement”) is made as of [Date] by and between SeaSpine Holdings Corporation, a Delaware corporation (the “Company”), and [Name] (“Indemnitee”). This Agreement supersedes and replaces any and all previous agreements between the Company and Indemnitee covering the subject matter of thi
May 31, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 29, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
May 17, 2019	SD	SPNE / SeaSpine Holdings Corporation SD SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM SD Specialized Disclosure Report SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001-36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) 5770 Armada Drive, Carlsbad, California 92008 (Address of principal e
May 17, 2019	CORRESP	SPNE / SeaSpine Holdings Corporation CORRESP - - CORRESP May 17, 2019 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549-4561 Attn: Mr.
May 1, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): May 1, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
May 1, 2019	EX-99.1	SeaSpine Reports First Quarter 2019 Financial Results Updates 2019 Financial Outlook; Raises Bottom End of Guidance Range Exhibit 99.1 SeaSpine Reports First Quarter 2019 Financial Results Updates 2019 Financial Outlook; Raises Bottom End of Guidance Range CARLSBAD, CA (May 1, 2019) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the quarter ended March 31, 2019 and updated it
May 1, 2019	EX-10.1	Tyler Lipschultz Letter Agreement, dated July 9, 2015 EX-10.1 2 ex101tylerlipschultzofferl.htm EXHIBIT 10.1 Exhibit 10.1 July 9, 2015 Tyler Lipschultz 12590 Cavallo Street San Diego, CA 92139 Dear Tyler: I am delighted to offer you the position of Vice President of Orthobiologics and Business Development for SeaSpine. In this position you will report to me, Keith Valentine, President and CEO for SeaSpine. Your start date is expected on or before Frid
May 1, 2019	10-Q	March 31, 2019 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
April 30, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits 8-K 1 spne8-kvalentineagreementa.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): April 30, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or oth
April 30, 2019	EX-10.1	Amendment to Employment Agreement entered into effective as of April 30, 2019 by and between SeaSpine Holdings Corporation and SeaSpine Orthopedics Corporation and Keith Valentine EX-10.1 2 spneexhibit101.htm EXHIBIT 10.1 Exhibit 10.1 AMENDMENT TO EMPLOYMENT AGREEMENT This Amendment to Employment Agreement (this “Amendment”) is entered into effective as of April 30, 2019 by and between SeaSpine Holdings Corporation, a Delaware corporation (“Holdings”), SeaSpine Orthopedics Corporation, a Delaware corporation (“SeaSpine,” and, together with Holdings, the “Company”) and Keith
April 17, 2019	DEFA14A	SPNE / SeaSpine Holdings Corporation DEFA14A SCHEDULE 14A INFORMATION (Rule 14a-101)PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) oDefinitive Proxy Statement ýDefinitive Additional Materials oSoliciting Material under §240.
April 17, 2019	DEF 14A	First Amendment to the SeaSpine Holdings Corporation 2015 Employee Stock Purchase Plan SCHEDULE 14A INFORMATION PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: oPreliminary Proxy Statement oConfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ýDefinitive Proxy Statement oDefinitive Additional Materials oSoliciting Material under §240.
March 4, 2019	EX-4.4	Form of Indenture for Subordinated Debt Securities EX-4.4 3 exhibit44-formsubordinated.htm EXHIBIT 4.4 Exhibit 4.4 SEASPINE HOLDINGS CORPORATION, ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securiti
March 4, 2019	EX-4.3	Form of Indenture for Senior Debt Securities EX-4.3 2 exhibit43-formseniorindent.htm EXHIBIT 4.3 Exhibit 4.3 SEASPINE HOLDINGS CORPORATION, ISSUER AND [TRUSTEE], TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE I DEFINITIONS 1 Section 1.1 Definitions of Terms 1 ARTICLE II ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.1 Designation and Terms of Securities 4 Se
March 4, 2019	S-3	SPNE / SeaSpine Holdings Corporation S-3 As filed with the Securities and Exchange Commission on March 1, 2019 Registration No.
March 1, 2019	424B5	The date of this prospectus supplement is March 1, 2019 Table of Contents 424B5 1 seaspine-atmprospectuscant.htm 424B5 Filed pursuant to Rule 424(b)(5) Registration Statement No. 333-213089 PROSPECTUS SUPPLEMENT (To Prospectus dated August 24, 2016) SeaSpine Holdings Corporation $50,000,000 Common Stock We have entered into a Controlled Equity OfferingSM Sales Agreement, or sales agreement, with Cantor Fitzgerald & Co. relating to our common shares offered by this prosp
March 1, 2019	EX-10.1	Controlled Equity OfferingSM Sales Agreement, dated March 1, 2019, by and between SeaSpine Holdings Corporation and Cantor Fitzgerald & Co. Exhibit 10.1 SeaSpine Holdings Corporation Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales Agreement March 1, 2019 Cantor Fitzgerald & Co. 499 Park Avenue New York, NY 10022 Ladies and Gentlemen: SeaSpine Holdings Corporation, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follow
March 1, 2019	8-K	Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 1, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
March 1, 2019	EX-3.2	Amended and Restated Bylaws of SeaSpine Holdings Corporation EXHIBIT 3.2 AMENDED AND RESTATED BYLAWS OF SEASPINE HOLDINGS CORPORATION (As amended as of February 28, 2019) ARTICLE I Meetings of Stockholders Section 1.1. Annual Meetings. The annual meeting of the stockholders of SeaSpine Holdings Corporation (the “Corporation”) for the election of directors (each, a “Director”) and for the transaction of such other business as properly may come before such me
March 1, 2019	10-K	Form 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NO.
February 28, 2019	EX-3.1	Amended and Restated Bylaws, as amended to date EXHIBIT 3.1 AMENDED AND RESTATED BYLAWS OF SEASPINE HOLDINGS CORPORATION (As amended as of February 28, 2019) ARTICLE I Meetings of Stockholders Section 1.1. Annual Meetings. The annual meeting of the stockholders of SeaSpine Holdings Corporation (the “Corporation”) for the election of directors (each, a “Director”) and for the transaction of such other business as properly may come before such me
February 28, 2019	8-K	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 28, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
February 27, 2019	EX-99.1	SeaSpine Announces Fourth Quarter and Full-Year 2018 Results and Reaffirms 2019 Revenue Guidance Exhibit 99.1 SeaSpine Announces Fourth Quarter and Full-Year 2018 Results and Reaffirms 2019 Revenue Guidance CARLSBAD, CA (February 27, 2019) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31, 2018 and reaffir
February 27, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 27, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
February 19, 2019	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 19, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.
February 19, 2019	EX-99.1	SeaSpine Appoints Kim Commins-Tzoumakas and Renee Gaeta to its Board of Directors Exhibit 99.1 SeaSpine Appoints Kim Commins-Tzoumakas and Renee Gaeta to its Board of Directors CARLSBAD, CA. (February 19, 2019) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Kim Commins-Tzoumakas and Renee Gaeta as members of the Company’s Board of Director
February 14, 2019	SC 13G/A	SPNE / SeaSpine Holdings Corporation / First Light Asset Management, LLC - AMENDMENT TO FORM SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934* SeaSpine Holdings Corporation (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securities) 81255T108 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to whi
February 11, 2019	EX-99.2	JOINT FILING AGREEMENT EX-99.2 3 a19-44462ex99d2.htm EX-99.2 Exhibit 99.2 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13G (including amendments thereto) with respect to the common stock, par value $0.01 per share of SeaSpine Holdings Corporation, and fu
February 11, 2019	EX-99.1	Group Members Richard E. Caruso, Ph.D. Tru St Partnership LP Provco Leasing Corporation The Uncommon Individual Foundation Exhibit 99.1 Group Members Richard E. Caruso, Ph.D. Tru St Partnership LP Provco Leasing Corporation The Uncommon Individual Foundation
February 11, 2019	SC 13G/A	SPNE / SeaSpine Holdings Corporation / CARUSO RICHARD E - SC 13G/A Passive Investment SC 13G/A 1 a19-44462sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* SEASPINE HOLDINGS CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 81255T 108 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Stateme
February 1, 2019	SC 13G/A	SPNE / SeaSpine Holdings Corporation / Novo A/S - SC 13G/A Passive Investment SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* SeaSpine Holdings Corp (Name of Issuer) Common Stock (Title of class of securities) 81255T108 (CUSIP number) December 31, 2018 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to wh
January 9, 2019	SC 13G	SPNE / SeaSpine Holdings Corporation / FALCON POINT CAPITAL, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Seaspine Holdings Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 81255T108 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
January 7, 2019	EX-99.1	SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2018 EX-99.1 2 q418exhibit991.htm EXHIBIT 99.1 EXHIBIT 99.1 SeaSpine Announces Preliminary Results for Fourth Quarter and Full-Year 2018 CARLSBAD, CA. (January 7, 2019) - SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full-year
January 7, 2019	8-K	Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 7, 2019 SeaSpine Holdings Corporation (Exact name of registrant as specified in its charter) Delaware 001- 36905 47-3251758 (State or other jurisdiction of incorporation) (Commission File Number) (I.

SPNE / SeaSpine Holdings Corp - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Mga Batayang Estadistika

SEC Filings

SEC Filings (Chronological Order)